Fundraising Fox

Michael Demurjian

Founder

Chief Executive Officer & Chairman at Aspargo Laboratories

New York, New York, United States

FoundedAspargo Laboratories

Find your path to Michael

27 people in our graph share verified history with Michael — schools, employers, funds. One of them is your warm intro.

About

Michael Demurjian is the Founder and CEO of Aspargo Laboratories, Inc., a pharmaceutical and MedTech company focused on oral spray formulations and drug delivery systems. The company's lead product, HEZKUE®, is an oral sildenafil spray approved in several EU countries and Mexico, with a U.S. telehealth launch planned for 2025, and its pipeline includes an oral spray formulation of metformin. Before founding Aspargo, Demurjian served as COO, CFO, and a board member of Tyme Inc. (NASDAQ: TYME), where he was involved in raising over $50 million and taking the company through its IPO.

Chief Executive Officer & Chairman at Aspargo Laboratories

Experience

  1. Aspargo Laboratories, Inc.Founder and CEO of Aspargo Laboratories Inc.current2020 — present
  2. Tyme IncCo-Founder/Chief Operating Officer2009 — 2019New York City Metropolitan Area
  3. Luminant Biosciences LLC.President and CEO2008 — 2013New Jersey, New York
  4. KITCHEN CONCEPTS LLCCo-founder and CEO2007 — 2010New York City Metropolitan Area
  5. Mikronite Technologies Group Inc. (Medical)Co-founder and Director of Marketing and Sales1998 — 2007New Jersey

Skills & more

Business Development7Manufacturing1Marketing1Marketing Strategy1Mergers & Acquisitions1New Business Development1Product Development1Project Planning1Public Relations1Strategic Partnerships1BiotechnologyLeadership6
+2 moreManagementStrategic Planning

From Michael's professional profile.

Frequently asked questions

Who is Michael Demurjian?
Michael Demurjian is the Founder and CEO of Aspargo Laboratories, Inc., a pharmaceutical and MedTech company focused on oral spray formulations and drug delivery systems. The company's lead product, HEZKUE®, is an oral sildenafil spray approved in several EU countries and Mexico, with a U.S. telehealth launch planned for 2025, and its pipeline includes an oral spray formulation of metformin. Before founding Aspargo, Demurjian served as COO, CFO, and a board member of Tyme Inc. (NASDAQ: TYME), where he was involved in raising over $50 million and taking the company through its IPO.
Where does Michael Demurjian work?
Michael Demurjian is Chief Executive Officer & Chairman of Aspargo Laboratories.
What companies did Michael Demurjian found?
Michael Demurjian founded Aspargo Laboratories.
Where did Michael Demurjian go to school?
Michael Demurjian studied at New York University (BA Economics. Continued studies, Economics, Business/Managerial Economics).

Founder mafias

Same school